The Food and Drug Administration is poised to order JUUL e-cigarettes off the U.S. market after years of scrutiny over company marketing practices and fears its products fueled the youth vaping crisis, according to a report in the Wall Street Journal.
The FDA could announce the move as soon as Wednesday after a nearly two-year review of the company, the newspaper reported.
JUUL faced intense scrutiny after lawmakers and regulators pointed to its products as the main driver of youth vaping in recent years. Critics said its trendy pods were easy to conceal from parents and teachers.